New eye implant aims to lower pressure in glaucoma patients

NCT ID NCT06176170

Ongoing Disease control Sponsor: VividWhite Pty Ltd Source: ClinicalTrials.gov ↗

First seen Oct 01, 2025 · Last updated May 23, 2026 · Updated 32 times

Summary

This study tests a new surgical implant called VividWhite (VW-51) for people with glaucoma. The goal is to safely lower eye pressure and reduce the need for eye drops. 65 participants will be followed for 12 months to see if the implant works and is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Cataract & Eye Surgery Centre

Doncaster East, Victoria, 3109, Australia
Cerulea Clinical Trials, Centre for Eye Research Australia

East Melbourne, Victoria, 3002, Australia
Eye Surgery Associates

Vermont South, Victoria, 3133, Australia
Flinders Medical Centre

Bedford Park, South Australia, 5042, Australia
Melbourne Eye Specialists

Fitzroy, Victoria, 3065, Australia
Sydney Eye Hospital

Sydney, New South Wales, 2000, Australia

Conditions

Explore the condition pages connected to this study.

GLAUCOMA